Nisha R Acharya

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Mooren''s ulcer following extracapsular cataract extraction
    N R Acharya
    The Francis I Proctor Foundation, University of California, San Francisco USA
    Eur J Ophthalmol 18:351-5. 2008
  2. ncbi Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema
    Nisha R Acharya
    F I Proctor Foundation, University of California, San Francisco, San Francisco, California 94143 0412, USA
    Retina 31:1871-6. 2011
  3. ncbi Ranibizumab for refractory uveitis-related macular edema
    Nisha R Acharya
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143, USA
    Am J Ophthalmol 148:303-309.e2. 2009
  4. ncbi Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment
    Aileen Sy
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA
    Invest Ophthalmol Vis Sci 53:267-72. 2012
  5. ncbi The clinical differentiation of bacterial and fungal keratitis: a photographic survey
    Cyril Dalmon
    the F I Proctor Foundation and Department of Ophthalmology, University of California, San Francisco, San Francisco, California
    Invest Ophthalmol Vis Sci 53:1787-91. 2012
  6. ncbi Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures
    Robert E Fintelmann
    Francis I Proctor Foundation for Research in Ophthalmology, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 0412, USA
    Arch Ophthalmol 129:399-402. 2011
  7. ncbi Practice patterns and opinions in the treatment of acanthamoeba keratitis
    Catherine E Oldenburg
    From the F I Proctor Foundation and Department of Ophthalmology, University of California, San Francisco, San Francisco, CA Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Il Department of Surgery, Department of Microbiology and Immunology, Dartmouth Medical School, Hanover, NH and Department of Ophthalmology and Vision Science, University of California, Davis Eye Center, Sacramento, CA
    Cornea 30:1363-8. 2011
  8. ncbi Depression and visual functioning in patients with ocular inflammatory disease
    Ying Qian
    Francis I Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    Am J Ophthalmol 153:370-378.e2. 2012
  9. ncbi Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis
    Allison R Loh
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143 0412, USA
    Am J Ophthalmol 150:534-542.e2. 2010
  10. ncbi Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease
    Yousuf Khalifa
    F I Proctor Foundation, University of California, San Francisco, California 94143 0412, USA
    Ocul Immunol Inflamm 17:431-3. 2009

Research Grants

  1. Predicting and Improving Clinical Outcomes for Bacterial Keratitis
    Nisha Acharya; Fiscal Year: 2007

Collaborators

Detail Information

Publications17

  1. ncbi Mooren''s ulcer following extracapsular cataract extraction
    N R Acharya
    The Francis I Proctor Foundation, University of California, San Francisco USA
    Eur J Ophthalmol 18:351-5. 2008
    ..Prior cataract surgery is a recognized risk factor for the development of Mooren''s ulcer, but the demographic and clinical features of a large cohort of such patients have not been described...
  2. ncbi Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema
    Nisha R Acharya
    F I Proctor Foundation, University of California, San Francisco, San Francisco, California 94143 0412, USA
    Retina 31:1871-6. 2011
    ..To describe an observed therapeutic effect of ranibizumab in untreated contralateral eyes of patients with bilateral uveitis-related cystoid macular edema...
  3. ncbi Ranibizumab for refractory uveitis-related macular edema
    Nisha R Acharya
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143, USA
    Am J Ophthalmol 148:303-309.e2. 2009
    ....
  4. ncbi Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment
    Aileen Sy
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA
    Invest Ophthalmol Vis Sci 53:267-72. 2012
    ..To compare the clinical course and effect of adjunctive corticosteroid therapy in Pseudomonas aeruginosa with those of all other strains of bacterial keratitis...
  5. ncbi The clinical differentiation of bacterial and fungal keratitis: a photographic survey
    Cyril Dalmon
    the F I Proctor Foundation and Department of Ophthalmology, University of California, San Francisco, San Francisco, California
    Invest Ophthalmol Vis Sci 53:1787-91. 2012
    ..ClinicalTrials.gov number, NCT00324168.)...
  6. ncbi Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures
    Robert E Fintelmann
    Francis I Proctor Foundation for Research in Ophthalmology, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 0412, USA
    Arch Ophthalmol 129:399-402. 2011
    ..To determine whether recent use of topical fluoroquinolones is a risk factor for in vitro fluoroquinolone resistance in Staphylococcus aureus ocular isolates...
  7. ncbi Practice patterns and opinions in the treatment of acanthamoeba keratitis
    Catherine E Oldenburg
    From the F I Proctor Foundation and Department of Ophthalmology, University of California, San Francisco, San Francisco, CA Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Il Department of Surgery, Department of Microbiology and Immunology, Dartmouth Medical School, Hanover, NH and Department of Ophthalmology and Vision Science, University of California, Davis Eye Center, Sacramento, CA
    Cornea 30:1363-8. 2011
    ..Management of acanthamoeba keratitis remains challenging for ophthalmologists. We conducted a survey of members of The Cornea Society to elicit expert opinions on the diagnosis and treatment of acanthamoeba keratitis...
  8. ncbi Depression and visual functioning in patients with ocular inflammatory disease
    Ying Qian
    Francis I Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    Am J Ophthalmol 153:370-378.e2. 2012
    ..To characterize the level of depression in patients with ocular inflammatory disease and to determine predictors of depression in this population...
  9. ncbi Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis
    Allison R Loh
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143 0412, USA
    Am J Ophthalmol 150:534-542.e2. 2010
    ..To calculate the incidence rates of ocular complications and vision loss in HLA-B27-associated uveitis and to explore the effect of chronic inflammation on clinical outcomes...
  10. ncbi Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease
    Yousuf Khalifa
    F I Proctor Foundation, University of California, San Francisco, California 94143 0412, USA
    Ocul Immunol Inflamm 17:431-3. 2009
    ..To describe the use of fluocinolone acetonide implants (Retisert) in Vogt-Koyanagi-Harada disease (VKH)...
  11. ncbi Treatment of pediatric vogt-koyanagi-harada syndrome with infliximab
    Yousuf M Khalifa
    F I Proctor Foundation, University of California at San Francisco, San Francisco, California, USA
    Ocul Immunol Inflamm 18:218-22. 2010
    ..Conclusions: Infliximab as adjunctive therapy in pediatric VKH showed a benefit in reducing systemic corticosteroid exposure in 1 patient, but incomplete timely resolution of inflammation in another patient...
  12. ncbi Infliximab and adalimumab for uveitis
    Joseph N Martel
    Department of Ophthalmology, University of California, San Francisco, California 94143 0412, USA
    Ocul Immunol Inflamm 20:18-26. 2012
    ..To describe the corticosteroid-sparing success in controlling chronic uveitis in patients treated with TNF? inhibitors...
  13. ncbi Juvenile idiopathic arthritis-associated uveitis
    Ying Qian
    F I Proctor Foundation, San Francisco, California, USA
    Curr Opin Ophthalmol 21:468-72. 2010
    ..To describe recent evidence from the literature pertaining to juvenile idiopathic arthritis (JIA)-associated uveitis...
  14. ncbi Corticosteroid-sparing therapy: practice patterns among uveitis specialists
    Elizabeth Esterberg
    F I Proctor Foundation, University of California San Francisco, Room S309, 513 Parnassus Avenue, San Francisco, CA, 94143 0412, USA
    J Ophthalmic Inflamm Infect 2:21-8. 2012
    ..This study aims to determine uveitis specialists' practice patterns, preferences, and perceptions of corticosteroid-sparing therapies for the initial treatment of chronic noninfectious uveitis...
  15. ncbi Cigarette smoking as a risk factor for uveitis
    Phoebe Lin
    F I Proctor Foundation, University of California, San Francisco, California 94143 0944, USA
    Ophthalmology 117:585-90. 2010
    ..To determine the association between tobacco smoking history and uveitis...
  16. ncbi Epidemiology of uveitis in children
    Agnieszka Nagpal
    FI Proctor Foundation University of California, San Francisco 513 Parnassus Ave, S-334 San Francisco, CA 94143, USA
    Int Ophthalmol Clin 48:1-7. 2008
  17. ncbi Does in vitro susceptibility predict clinical outcome in bacterial keratitis?
    Aiyin Chen
    F I Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, San Francisco, California 94143, USA
    Am J Ophthalmol 145:409-412. 2008
    ..To determine whether clinical outcomes in bacterial keratitis are associated with antibiotic susceptibility...

Research Grants2

  1. Predicting and Improving Clinical Outcomes for Bacterial Keratitis
    Nisha Acharya; Fiscal Year: 2007
    ..Our goal is to provide data to allow clinicians to risk-stratify patients with bacterial corneal ulcers in an evidence-based manner. ..